Aseven-state pilot project will study the best way to help oldersmokers kick their nicotine habit. The program, financed by theCenters for Medicare & Medicaid Services (CMS), will testcounseling in person and by phone, a prescription smoking cessationdrug, nicotine patches, and education materials. The 1-year MedicareStop Smoking Program will be conducted in Alabama, Florida, Missouri,Nebraska, Ohio, Oklahoma, and Wyoming, which were selectedusing a formula that included the prevalence of older smokers. Additionalinformation on the program is available at 1-866-652-3446.
A seven-state pilot project will study the best way to help older smokers kick their nicotine habit. The program, financed by the Centers for Medicare & Medicaid Services (CMS), will test counseling in person and by phone, a prescription smoking cessation drug, nicotine patches, and education materials. The 1-year Medicare Stop Smoking Program will be conducted in Alabama, Florida, Missouri, Nebraska, Ohio, Oklahoma, and Wyoming, which were selected using a formula that included the prevalence of older smokers. Additional information on the program is available at 1-866-652-3446.
Efficacy and Safety of Zolbetuximab in Gastric Cancer
Zolbetuximab’s targeted action, combined with manageable adverse effects, positions it as a promising therapy for advanced gastric cancer.
These data support less restrictive clinical trial eligibility criteria for those with metastatic NSCLC. This is especially true regarding both targeted therapy and immunotherapy treatment regimens.